Effect of 532nm laser combined with a traditional Chinese patent drug in the treatment of severe non proliferative diabetic retinopathy
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [18]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To observe the clinical effect of 532nm laser combined with a traditional Chinese patent called He xue ming mu tablets in the treatment of diabetic retinopathy in patients with severe non proliferative diabetic retinopathy.

    METHODS: A total of 120 patients(226 eyes)diagnosed by the clinic for severe non-proliferative diabetic retinopathy diabetic retinopathy patients were randomly divided into treatment group and control group. The patients underwent combined therapy defined as treatment group(Group A), the treatment process and took He xue ming mu tablets orally for 1-3mo defines a separate line. The patients with laser photocoagulation treatment as the control group(Group B). After 1, 2 and 3mo after treatment, the retinal hemorrhage and visual function of the patients in the two groups were observed, and the fundus fluorescein angiography in 3mo after treatment was observed.

    RESULTS: Two groups of patients in the different treatment measures were taken after 1-2mo, patients suffering from eye visual function recovery was significantly better than the control group(P<0.05). But up to 2mo after the treatment, the treatment group and the control group eyes visual function index was no significant difference. Compared with the control group, the patients in the treatment group had significant advantages in terms of retinal hemorrhage, exudation, edema and fundus(P<0.05).

    CONCLUSION: The severe non-proliferative diabetic retinopathy diabetic retinopathy treated by laser combined with He xue ming mu tablets treatment, can effectively shorten the eyes with visual function recovery speed, and can promote the absorption of retinal hemorrhage and exudation rate, reduce the secondary damage to the laser has a certain role.

    Reference
    1 Chew EY, Davis MD, Danis RP,et al.The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes(ACCORD)Eye Study. Ophthalmology 2014; 121(12):2443-2451
    2 Kempen JH, O'Colmain BJ, Leske MC, et al. The prevalence of diabetie retinopathy among adults in the United States.Arch Ophthalmol 2004; 122(4):552-563
    3钟颖,梁永强,袁红枝,等.激光治疗不同分期糖尿病视网膜病变的疗效观察.临床和实验医学杂志2014; 13(14):1157-1159
    4 Fenwick EK, Lamoureux EL. Effect of pan-retinal hotocoagulation treatment on vision-related quality of life of patients with proliferativediabetic retinopathy. Retina 2013; 33(7):1479
    5 Girach A, Aiello LP, Milton RC, et al. Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy. Eye(Lond) 2009; 23(1):209-214
    6Jørgensen C, Bek T. Increasing oxygen saturation in larger retinal vessels after photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci 2014; 55(8):5365-5369
    7 Shiraya T, Kato S, Shigeeda T, et al. Comparison of burn size after retinal photocoagulation by conventional and high-power short-duration methods. Acta Ophthalmol 2014; 92(7):585-586
    8 Rema M, Sujatha P, Pradeepa R. Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors. Indian J Ophthalmol 2005; 53(2):93-99
    9 Shrestha S, Karki DB, Byanju R, et al. Visual outcome of laser treatment in diabetic retinopathy. Kathmandu Univ Med J(KUMJ) 2007; 5(1):72-80
    10 Du B, Zhang H, Chan HH, et al. Retinal function and morphology of severe non-proliferative diabetic retinopathy before and after retinal photocoagulation. Clin Exp Optom 2011; 94(3):284-290
    11李欢,罗向霞.糖尿病视网膜病变激光光凝治疗对视野影响的研究进展.中国中医眼科杂志2015; 3:217-219
    12 Simunovic MP, Maberley DA.Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: A Systematic Review and Meta-Analysis. Retina 2015; 35(10):1931-1942
    13 Mahdy RA, Nada WM, Hadhoud KM, et al. The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye(Lond) 2010; 24(10):1576-1584
    14董如娇,陈芳,赵霞,等.全视网膜光凝联合药物治疗糖尿病视网膜病变的临床观察.中国中医眼科杂志2015; 2:114-117
    15高志强.凉血散瘀汤加味治疗瘀热阻络证型非增殖期糖尿病视网膜病变的临床观察.中医临床研究2014; 6(22):41-42
    16欧阳菁.中药治疗非增殖期糖尿病视网膜病变26例观察.实用中医药杂志2013; 4:257-258
    17丛建秀.止血散瘀明目汤治疗非增殖期糖尿病视网膜病变的疗效研究.中医临床研究2015; 7(14):25-26
    18庞朝善,杨赞章.凉血散瘀汤加味治疗非增殖期糖尿病视网膜病变的临床观察.中国中医眼科杂志2013; 3:169-172
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Xiang-Lei Chen, Li-Ming Tao, Yuan Xu,/et al.Effect of 532nm laser combined with a traditional Chinese patent drug in the treatment of severe non proliferative diabetic retinopathy. Guoji Yanke Zazhi( Int Eye Sci) 2016;16(12):2268-2271

Copy
Share
Article Metrics
  • Abstract:1413
  • PDF: 1148
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:August 15,2016
  • Revised:November 14,2016
  • Online: November 23,2016